FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Labeling for Animal Drugs Revision

Federal Register proposed rule: FDA proposes to revise the requirements for the content and format of labeling for approved or conditionally approved ...

latest-news-card-1
Medical Devices

Windstone Medical Recalls Surgical Kits

Windstone Medical Packaging recalls its Local Lower Extremity Pack, In-House Ocular Pack and Closure Kit in response to Nurse Assists 2023 ongoing rec...

latest-news-card-1
Human Drugs

FDA Rejects Viatris/Mapi Multiple Sclerosis Drug

FDA sends Viatris/Mapi Pharma a complete response letter on the NDA for GA Depot 40 mg, a long-acting glatiramer acetate being investigated as a once-...

latest-news-card-1
Medical Devices

Abbott Recalls HeartMate Touch System

Abbott recalls its HeartMate Touch System (version 1.0.32) due to the risk of an unexpected pump stop or start.

latest-news-card-1
FDA General

$500 Million Boost to FDA in Presidents Budget Proposal

President Biden seeks a $500 million boost in FDAs spending in fiscal year 2025, which is 7.4% more than the current $6.7 billion spending level in FY...

latest-news-card-1
Human Drugs

Draft Guide on Developing Early Stage Alzheimers Drugs

FDA posts a draft guidance entitled Early Alzheimers Disease: Developing Drugs for Treatment with a focus on the ultimate goal of delaying or halting/...

latest-news-card-1
Federal Register

Docket Corrected on Covid Trial Guidance

Federal Register notice: FDA corrects a 2/22 notice announcing the availability of a final guidance on assessing Covid19-related symptoms in outpatien...

latest-news-card-1
Federal Register

Blood Products Advisory Panel Meeting

Federal Register notice: FDA announces a 5/9 Blood Products Advisory Committee meeting on strategies to reduce the risk of transfusion-transmitted mal...

latest-news-card-1
Human Drugs

J&J sBLA for Tremfya in Ulcerative Colitis

Johnson & Johnson files a supplemental BLA for Tremfya (guselkumab) for treating adults with moderately to severely active ulcerative colitis.

latest-news-card-1
Medical Devices

Panel Backs Lumisight Breast Surgical Imaging

An FDA advisory committee votes 16-2 in support of approving a Lumicell NDA for Lumisight (pegulicianine), an optical imaging agent for use in patient...